| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.029 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |